V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10393780 | 10040835 | null | 0 | Palliative (P) | 2018-04-18 | 2018-05-14 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101112347 |
| 10393792 | 10040836 | 1.59 | 58.6 | Neo-adjuvant (N) | 2019-02-16 | 2019-02-22 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100349977 |
| 10393798 | 10040837 | 1.47 | 78.5 | 03 | 2020-01-16 | 2020-01-22 | POMALIDOMIDE | 2 | null | SUNITINIB | 100784295 |
| 10393817 | 10040838 | 1.73 | 77.25 | null | 2019-12-27 | 2020-01-04 | Avelumab | 02 | null | AVELUMAB | 101255362 |
| 10393864 | 10040840 | 1.62 | 68.4 | null | 2019-10-21 | 2019-10-28 | Capecitabine + Cisplatin + RT | N | N | PAZOPANIB | 101229714 |
| 10393881 | 10040841 | 1.55 | 41.6 | null | 2018-10-06 | 2018-10-06 | Palbociclib | 02 | null | PALBOCICLIB | 101109475 |
| 10393924 | 10040842 | 1.7 | 63.7 | null | 2019-07-19 | 2019-08-06 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100544328 |
| 10393926 | 10040843 | 1.58 | 114.2 | Palliative (P) | 2017-01-31 | 2017-01-31 | Capecitabine + Cisplatin + RT | 02 | N | DABRAFENIB + TRAMETINIB | 101412472 |
| 10393937 | 10040844 | 1.73 | 79.6 | Palliative (P) | 2019-05-11 | 2019-05-12 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101486506 |
| 10394017 | 10040845 | 1.82 | 83.8 | Palliative (P) | 2020-02-21 | 2020-02-21 | Sunitinib | 02 | N | VENETOCLAX | 100469794 |
| 10394052 | 10040846 | 1.61 | 105.8 | null | 2016-05-21 | 2016-05-23 | DABRAFENIB + TRAMETINIB | 02 | null | CAPECITABINE + GEMCITABINE | 101138085 |
| 10394065 | 10040847 | 1.62 | 56.5 | 03 | 2018-09-23 | 2018-10-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100910341 |
| 10394078 | 10040848 | 1.71 | 48.2 | Adjuvant (A) | 2018-12-08 | 2018-12-08 | Avelumab | 02 | N | AVELUMAB | 100787896 |
| 10394092 | 10040849 | null | null | null | 2018-11-02 | 2018-11-13 | CTD Attenuated (Thalidomide 50mg) | 02 | null | VENETOCLAX | 101218214 |
| 10394095 | 10040850 | 1.71 | 88 | Neo-adjuvant (N) | 2019-12-17 | 2019-12-17 | BCG Intravesical | 02 | N | CISPLATIN + VINORELBINE | 101313413 |
| 10394104 | 10040851 | 1.58 | null | 03 | 2018-07-28 | 2018-08-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100036641 |
| 10394122 | 10040853 | 1.82 | null | Palliative (P) | 2019-01-23 | 2019-05-03 | Cytarabine Low Dose | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101830943 |
| 10394137 | 10040854 | 1.8 | 64.8 | Palliative (P) | 2019-07-15 | 2019-07-29 | Pazopanib | N | N | CVP R | 100077605 |
| 10394208 | 10040856 | null | null | null | 2018-08-07 | 2018-08-13 | DARATUMUMAB | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101753436 |
| 10394259 | 10040859 | 1.72 | 97.6 | null | 2019-12-05 | 2019-12-05 | CHOP | Y | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101583446 |
| 10394288 | 10040860 | 1.7 | 92.4 | null | 2017-03-04 | 2017-03-07 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101406219 |
| 10394305 | 10040861 | 1.72 | 71.25 | Neo-adjuvant (N) | 2019-02-28 | 2019-03-08 | Pazopanib | 02 | N | CYTARABINE | 100722742 |
| 10394309 | 10040862 | 1.63 | 58.7 | Palliative (P) | 2018-05-06 | 2018-05-11 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100658864 |
| 10394311 | 10040863 | 1.69 | 90 | null | 2018-11-24 | 2018-12-01 | DABRAFENIB + TRAMETINIB | 02 | null | SUNITINIB | 101444894 |
| 10394382 | 10040867 | 1.68 | 50 | null | 2017-11-09 | 2017-11-19 | IPILIMUMAB + NIVOLUMAB | N | N | IPILIMUMAB + NIVOLUMAB | 100687817 |
| 10394438 | 10040868 | 0 | 83 | 03 | 2016-12-16 | 2016-12-27 | BUSULFAN | 02 | N | CAPECITABINE + CISPLATIN | 101616712 |
| 10394516 | 10040869 | 1 | 81.9 | Palliative (P) | 2019-05-04 | 2019-05-04 | Sunitinib | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101465613 |
| 10394555 | 10040870 | null | null | Palliative (P) | 2019-01-04 | 2019-01-05 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101766674 |
| 10394662 | 10040871 | 1.59 | 70.05 | null | 2018-03-23 | 2018-04-02 | Acalabrutinib | 2 | null | ACALABRUTINIB | 100299149 |
| 10394712 | 10040873 | 1.66 | 57 | Palliative (P) | 2018-01-06 | 2018-01-06 | Pazopanib | 02 | N | TRIAL | 101013147 |
| 10394802 | 10040874 | 1.79 | 95.8 | null | 2008-05-09 | 2018-08-26 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100768299 |
| 10394861 | 10040876 | 1.63 | 113.5 | null | 2018-04-26 | 2018-04-26 | Carboplatin + Pembrolizumab + Pemetrexed | null | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100566104 |
| 10394896 | 10040877 | 1.52 | 61.6 | Adjuvant (A) | 2019-05-26 | 2019-06-07 | Acalabrutinib | 02 | null | ACALABRUTINIB | 100511849 |
| 10395032 | 10040878 | 1.55 | 93.7 | Palliative (P) | 2019-10-29 | 2019-10-29 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100573775 |
| 10395131 | 10040880 | 1.84 | 67.7 | 03 | 2017-04-14 | 2017-04-19 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | BUSULFAN | 101733712 |
| 10395187 | 10040881 | 0 | 0 | null | 2017-10-20 | 2017-11-01 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101490823 |
| 10395191 | 10040882 | 1.8 | 88.8 | null | 2020-07-13 | 2020-07-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100242839 |
| 10395217 | 10040884 | 1.74 | 81.4 | null | 2019-01-04 | 2019-01-09 | Venetoclax | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101223728 |
| 10395339 | 10040885 | 1.55 | 52.2 | Palliative (P) | null | 2018-08-14 | MITOMYCIN | N | N | DARATUMUMAB | 101335491 |
| 10395368 | 10040886 | null | null | Palliative (P) | 2017-07-20 | 2017-08-24 | CHOP R - 21 days | 02 | N | CHOP R | 100575933 |
| 10395391 | 10040887 | 1.64 | 80.3 | Palliative (P) | 2019-10-28 | 2019-10-28 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100933024 |
| 10395405 | 10040888 | 1.64 | 84.6 | 03 | 2018-10-10 | 2018-10-12 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101128976 |
| 10395413 | 10040890 | 1.64 | 78.6 | Palliative (P) | 2017-12-20 | 2017-12-21 | FEC + DOCETAXEL | 02 | N | CISPLATIN + FLUOROURACIL | 100970947 |
| 10395611 | 10040892 | 1.69 | 67.5 | Palliative (P) | 2018-09-18 | 2018-09-21 | CISPLATIN + VINORELBINE | 02 | N | TRIAL | 100710720 |
| 10395617 | 10040893 | null | 45 | Palliative (P) | 2018-04-26 | 2018-04-26 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100110850 |
| 10395703 | 10040894 | 1.59 | 74.9 | Neo-adjuvant (N) | 2022-05-21 | 2022-05-21 | Cyclophosphamide + Dex + Rituximab | 02 | N | CISPLATIN + FLUOROURACIL | 100363186 |
| 10395755 | 10040895 | 1.57 | 88 | Neo-adjuvant (N) | 2021-12-04 | 2021-12-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100414067 |
| 10395783 | 10040896 | null | 81.6 | Curative (C) | 2010-11-15 | 2016-06-27 | Busulfan Oral | 02 | N | MITOMYCIN | 100563493 |
| 10395797 | 10040897 | 0 | 88.8 | null | 2022-01-16 | 2022-01-30 | Temozolomide + RT | N | null | TEMOZOLOMIDE | 101450326 |
| 10395862 | 10040898 | 1.67 | 100.2 | null | 2019-08-29 | 2019-09-02 | Folfirinox | 01 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100254027 |